Skip to main content

Table 2 Variables related with SVR at univariate and multivariate analysis (ITT).

From: Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV

  Univariate Analysis Multivariate Analysis
Variables OR
(IC 95%)
pvalue OR
(IC 95%)
pvalue
HCV-RNA >500.000 IU/ml 0.5 (0.3-0.7) 0.0009 0.39 (0.24-0.66) 0.0004
PegIFN alfa-2b vs alfa-2a 0.5 (0.3-0.9) 0.014 0.5 (0.27-0.93) 0.033
Stop PegIFN 0.1 (0.1-0-2) <0.0001 0.19 (0.1-0.4) <0.0001
Stop RBV 0.3 (0.2-0.5) <0.0001 0.34 (0.17-0.69) 0.0026
PLT <130.000 cell/mm3 0.35 (0.2-0.6) 0.0004 0.45 (0.2-0.99) 0.048
Cirrhosis 0.6 (0.3-1.2) 0.15 1.37 (0.57-3.3) 0.47
Age >45 years 0.7 (0.45-1) 0.11 0.71 (0.4-1.26) 0.25
HIV infection 0.6 (0.4-1.1) 0.066 0.85 (0.32-2.23) 0.74
RBV reduction 1.5 (0.8-2.9) 0.25   
PegIFN reduction 1.2 (0.6-2.6) 0.59   
Gender (male vs female) 0.6 (0.4-0.9) 0.34 0.64 (0.36-1.14) 0.13
HCV genotype 2 vs 3 0.75 (0.48-1.16) 0.2 0.97 (0.5-1.8) 0.93
Variables SVR no SVR yes p value OR
(IC 95%)
p value
Weeks of treatment, mean (SD) 20.3 (15.4) 24.3 (12.2) 0.0006 1 (0.9-1.1) 0.22